Technology | July 29, 2008

Anchorseed for Prostate Brachytherapy Offers Two Isotopes

Brachysciences' AnchorSeed for prostate brachytherapy has a design is intended to give existing low dose rate brachytherpay sources enhanced ability to maintain their position within tissue, thereby allowing physicians to confidently place seeds in more strategic and beneficial locations. It is designed to work with Mick Applicators as well as with Pre-Loaded Needles.

AnchorSeed has been designed to improve loose seed fixity and reduce misalignment, migration and vacuum phenomena. The "anchor effect" provides added confidence in placing seeds closer to the periphery, within the peri-urethral areas and closer to the apex and base.

AnchorSeed for prostate brachytherapy is now available with a second isotope, TheraSeed palladium-103, offering physicians the option of utilizing AnchorSeed with the two most commonly used isotopes for prostate brachytherapy, iodine-125 and palladium-103.

AnchorSeed’s patent pending design is intended to give existing low dose rate prostate brachytherapy sources the ability to maintain their position within tissue, thereby allowing physicians to confidently place seeds in more strategic and beneficial locations than in the past. It is designed for use both with Mick Applicators as well as with pre-loaded needles.

Utilizing a bioabsorbable polymer as in BrachySciences’ portfolio of strand products, AnchorSeed’s design reportedly offers an anchoring effect to help significantly reduce seed misalignment and seed migration. This ability to better maintain its position now allows physicians to place seeds where they may have hesitated in the past.

Overlay Init